Friday, November 05, 2021
8:00 PM - 10:00 PM CT
Mirna Chehade, MD
Associate Professor of Pediatrics and Medicine
Director, Mount Sinai Center for Eosinophilic Disorders
Icahn School of Medicine at Mount Sinai
New York, New York
Ikuo Hirano, MD
Professor of Medicine (Gastroenterology and Hepatology)
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Jonathan Spergel, MD
Chief, Allergy Program
Children's Hospital of Philadelphia
Stuart E. Starr Chair of Pediatrics
Professor of Pediatrics
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania
Non-CME Corporate Forum
The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology.
There is no registration fee for attending this Non-CME Corporate Forum; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the meeting room early. Dinner will be provided.
This activity is supported by an independent grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Date and Time
Friday, November 5, 2021
8:00 PM-8:30 PM CT: Dinner & Registration
8:30 PM-10:00 PM CT: Call-a-Colleague™ Program
Dinner will be provided.
Target Audience
This program is intended for allergists/clinical immunologists, gastroenterologists, and other clinicians involved in the identification and management of patients with eosinophilic esophagitis (EoE).
Program Description
During this Call-a-Colleague™ program, specialists in allergy/immunology and eosinophilic gastrointestinal disease will discuss the disease burden, pathophysiology, diagnosis, and current management of eosinophilic esophagitis (EoE). Faculty will also present clinical trial evidence for emerging treatment options as well as considerations for patients with other atopic conditions. A unique feature of the program will be the “Call-a-Colleague” section where our specialists will elicit additional insight from their multidisciplinary team members, such as a dietitian, a psychologist, and a pediatric gastroenterologist. The clinicians will provide their expertise regarding the mental health burden among patients, the use of an elimination diet to resolve symptoms, and clinical issues pertaining to pediatric patients with EoE.
Learning Objectives
After completing this activity, participants will be better prepared to:
- Describe the pathophysiologic mechanisms underlying EoE development, with a focus on potential therapeutic targets
- Comprehensively assess pediatric and adult patients with suspected EoE to accelerate differential diagnoses and establish appropriate multidisciplinary care
- Compare the clinical profiles, available trial evidence, and drawbacks of current and emerging treatment strategies for EoE
- Longitudinally manage pediatric and adult patients with EoE based on symptoms, comorbidities, updated clinical guidelines, and therapeutic responses
- Communicate with patients, caregivers, and members of the multidisciplinary team to ensure continuity of care and promote shared clinical decision-making
Program Agenda
8:00–8:30 PM Registration & Dinner
8:30–8:40 PM Welcome & Preactivity Questions
8:40–8:55 PM An Overview of EoE: Burden & Pathophysiology
Call a Colleague: Patient testimonial
8:55–9:20 PM Diagnosis and Evaluation of Patients With EoE
Call a Colleague: Pathology Expert; Margaret Collins, MD
9:20–9:45 PM Long-term Multidisciplinary Management and Patient Communication
Call a Colleague: Dietitian; Bethany Doerfler, MS, RD, LDN
9:45–10:00 PM Postactivity Questions and Q&A Session
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Fee Information & Refund/Cancellation Policy
There is no fee for this activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Integritas prior to the live event at info@exchangecme.com.
Integritas Communications Contact Information
For questions about this activity, please contact Integritas Communications at info@exchangecme.com.
Register Now
19
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mobile County Health Dept. - In-Person Event |
Location: | Mobile, AL |
Faculty: | William S. Bradford, MD |
22
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Health Service Inc. - In-Person Event |
Location: | Montgomery, AL |
Faculty: | Audrey R. Lloyd, MD |
24
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:30 PM-1:30 PM CT |
Venue: | Cahaba Medical Care - In-Person Event |
Location: | Birmingham, AL |
Faculty: | Ellen F. Eaton, MD, MSPH, FIDSA |
01
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mostellar Medical - In-Person Event |
Location: | Irvington, AL |
Faculty: | William S. Bradford, MD |
15
2024
Tackling Chronic Inflammatory Airway Diseases
A Unified Picture of Disease Processes and Targeted Management
Time: | 6:00 PM-8:00 PM CT |
Venue: | Hyatt Regency Chicago, Grand GH |
Location: | Chicago, IL |
Faculty: | Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI |
15
2024
Tackling Chronic Inflammatory Airway Diseases
A Unified Picture of Disease Processes and Targeted Management
Time: | 6:30 PM-8:00 PM CT |
Venue: | Live Stream |
Location: | Live Stream |
Faculty: | Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI |
20
2024
An Expert Panel on Severe Asthma
From the Epithelium to Better Patient Outcomes
Time: | 6:30 PM-8:00 PM PT |
Venue: | Hilton Bayfront San Diego - Indigo Ballroom CGDH |
Location: | Indigo Ballroom CGDH |
Faculty: | Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc; Geoffrey Chupp, MD |
20
2024
An Expert Panel on Severe Asthma
From the Epithelium to Better Patient Outcomes
Time: | 6:30 PM-8:00 PM PT |
Venue: | Live Stream |
Location: | Live Stream |
Faculty: | Geoffrey Chupp, MD; Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc |
22
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mostellar Medical - In-Person Event |
Location: | Irvington, AL |
Faculty: | Audrey R. Lloyd, MD |